Comparaisons Financières Alkem Laboratories Limited
Actions
ALKEM
INE540L01014
Produits pharmaceutiques
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
5 489,95 INR | +0,56% | -2,61% | +5,52% |
15/11 | ALKEM LABORATORIES LIMITED : Nomura conserve son opinion neutre | ZM |
15/11 | Le bénéfice consolidé d'Alkem Laboratories augmente au cours du deuxième trimestre fiscal | MT |
Ajouter à une liste 0 sélectionné | Chiffre d'affaires ($) (N-1) | Marge nette (N-1) | Marge Opérationnelle (N-1) | ROE (N-1) | ROA (N-1) | Leverage (Dette/EBITDA) (N-1) | |
---|---|---|---|---|---|---|---|
1,49 Md | +14,18% | +15,36% | +18,55% | +12,24% | -0.16x | ||
34,12 Md | +15,36% | +20,68% | +48,93% | +9,23% | 2.6x | ||
32,72 Md | +36,03% | +44,16% | +88,07% | +30,12% | -0.03x | ||
85,16 Md | +41,28% | +32,25% | +34,91% | +14,32% | 0.21x | ||
54,32 Md | +8,95% | +45,64% | +143,18% | +14,46% | 1.82x | ||
60,12 Md | +0,61% | +10,33% | +9,18% | +3,56% | 2.77x | ||
66,57 Md | +19,58% | +32,77% | +45,73% | +16,71% | 0.85x | ||
45,81 Md | +13,01% | +31,73% | +29,77% | +11,48% | 1.66x | ||
45,44 Md | +32,69% | +36,03% | +25,37% | +12,37% | 0.67x | ||
28,19 Md | +23,83% | +47,53% | +202,85% | +12,37% | 3.07x | ||
58,5 Md | +3,62% | +15,90% | +11,37% | +4,96% | 3.8x | ||
45,25 Md | +12,54% | +29,42% | +13,65% | +4,27% | 0.55x | ||
45,01 Md | +17,83% | +37,30% | +51,57% | +8,36% | 1.55x | ||
27,12 Md | +20,89% | +38,66% | +38,46% | +13,49% | 1.34x | ||
7,31 Md | +29,29% | +39,52% | +21,30% | +23,34% | -1.57x | ||
38,66 Md | +16,25% | +28,97% | +52,48% | +10,55% | 1.29x | ||
10,53 Md | +12,53% | +13,21% | +12,80% | +7,95% | -2.01x | ||
14,41 Md | +9,28% | +22,55% | +6,37% | +3,05% | 3.01x | ||
28,04 Md | +3,38% | +5,02% | +2,10% | +0,36% | 4.66x | ||
Moyenne | 38,36 Md | +17,43% | +28,79% | +45,09% | +11,22% | 1,37x | |
Moyenne pondérée par Capi. | 45,68 Md | +20,18% | +30,96% | +56,48% | +13,29% | 1,48x |
- Bourse
- Actions
- Action ALKEM
- Secteur Alkem Laboratories Limited
- Comparaisons Financières
Zonebourse is also available in this country: United States.
Switch edition